748P Outcomes for patients (pts) with advanced endometrial cancer (aEC) who completed pembrolizumab (pembro) and continued lenvatinib (LEN) in the phase III Study 309/KEYNOTE-775

Makaleler > Tam Makale · 2023

Yazarlar: E. Colomba, D. Lorusso, H. Mackay, R. Moore, K. Yonemori, Y.M. Kim, U.A. Sanli, R. Xie, G. Barresi, J. McKenzie, V. Makker

Annals of Oncology, Uluslararası, Wos, 2023, cilt 34, ss S512-S513